Products
Inlive

Inlive

Inlive is an original preventive vaccine in the world, independently developed by Sinovac Biotech Ltd., which is mainly used to prevent the Hand-Foot-Month Disease(HFMD) caused by Enterovirus Type 71(...Details
Healive

Healive

Healive is the first inactivated hepatitis A vaccine developed in China by Chinese scientists at Sinovac, which retained the intellectual property rights. It brought to an end an era in which China di...Details
Bilive

Bilive

Bilive® is the first, and currently only, combined inactivated hepatitis A and B vaccine developed by Chinese scientists. The R&D and clinical trial period for Bilive was completed in only four years ...Details
Anflu

Anflu

Sinovac commenced development of its split influenza vaccine in 2001. The pre-clinical research was completed in 2004. The result of clinical trial for Anflu showed that it is well tolerated in childr...Details
Panflu

Panflu

Panflu® is an inactivated H5N1 influenza (avian flu) vaccine that was approved by State Food and Drug Administration in April 2008. This product was co-developed by Sinovac Biotech Co., Ltd and the Ch...Details
PANFLU.1

PANFLU.1

PANFLU.1 ®is the first Influenza A (H1N1) vaccine to be approved in the world and in China as the State Food and Drug Administration granted approval in September 2009. Details
Pipeline
Investor Relations
RSS订阅

Copyright © 2001-2019 Sinovac Biotech Ltd. All Rights Reserved.

Add: No. 39 Shangdi Xi Road, Haidian District, Beijing, P.R.C. 100085